Mark S. Levine, General Counsel at Flexion Therapeutics Inc (FLXN), sold 3,945 shares at $6.45 ($25K) on 2021-07-19, disclosed to the SEC on 2021-07-20.
Open-market sale of $25k FLXN by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IMVT | SELL | 2024-10-18 | $165K | — | Filing → |
| IMVT | SELL | 2024-08-23 | $206K | — | Filing → |
| IMVT | SELL | 2024-07-26 | $223K | — | Filing → |